BU BÖLÜM HAKKINDA
Join Creative Biolabs and Dr. Melita Irving to explore engineering strategies for adoptive T-cell therapy against cancer. This webinar examines tumor microenvironment barriers, co-engineered CAR-T cells, low-dose irradiation, and STOP-CAR design, highlighting approaches to improve T-cell function and integrate efficacy and safety into next-generation CAR and TCR therapies.
ingilizce
Amerika Birleşik Devletleri
TRANSKRİPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SON BÖLÜMLERİ ARA
The antibody-based pharmaceuticals resource library’s Podcast için geçmiş bölümleri ara.
BU PODCAST'IN DİĞER BÖLÜMLERİ
Join Creative Biolabs and Dr. Bruno Paiva to explore new approaches to evaluating the tumor immune microenvironment. This webinar examines blood cancer and immunity, B-cell maturation antigen, bispecific antibodies, myeloid-derived suppressor cells, and immune escape, connecting insights into tumor…
Join Creative Biolabs and Dr. Eytan Herzig to explore convertibleCAR-T technology for HIV research. This webinar explains how engineered T cells and HIV-targeting MicAbodies work together to recognize infected cells, highlighting the platform's modularity, multiplexed antibody targeting, and practi…
Join Creative Biolabs and Dr. James Naismith to explore the development of SARS-CoV-2 neutralizing single-domain antibodies. This webinar highlights a candidate showing promising therapeutic efficacy in a Syrian golden hamster model of COVID-19, offering insights into antibody development and the p…
Join Creative Biolabs and Dr. Francisco J. Quintana to explore how astrocytes regulate central nervous system inflammation. This webinar examines their functions in health and disease, cell-cell interactions, and long-term epigenetic control, highlighting emerging methods and research directions fo…
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan antibodybasedpharmaceuticalsresourcelibrary'e aittir.
DÜZENLE
Podcast veritabanını güncel tutmaya yardımcı olduğunuz için teşekkür ederiz.
